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Abstract
Background: Anatomic short femoral prostheses with a prominent lateral flare have the potential
to reduce stress-shielding in the femur through a more physiological stress distribution to the
proximal femur. We present the design rationale of a new short uncemented, proximally fixed
anatomic femoral implant and the study design of a prospective multi-centre trial to collect long-
term patient outcome and radiographic follow up data.
Methods: A prospective surveillance study (trial registry NCT00208555) in four European centres
(UK, Italy, Spain and Germany) with a follow up period of 15 years will be executed. The
recruitment target is 200 subjects, patients between the ages of 18 and 70 admitted for primary
cementless unilateral THA will be included. The primary objective is to evaluate the five-year
survivorship of the new cementless short stem. The secondary objectives of this investigation are
to evaluate the long term survivorship and the clinical performance of the implant, the impact on
the subjects health related Quality of Life and the affect of the prosthesis on bone mineral density.
Peri- and postoperative complications will be registered. Clinical and radiographic evaluation of
prosthesis positioning will be done post-operatively and at 3, 6, 12, 24, 60, 120 and 180 months
follow up.
Discussion: Shortening of the distal stem can maximise bone and soft tissue conservation. New
stem types have been designed to improve the limitations of traditional implants in primary THA.
A new, uncemented femoral short stem is introduced in this paper. A long-term follow up study
has been designed to verify stable fixation and to research into the clinical outcome. The results of
this trial will be presented as soon as they become available.
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Background
Although substantial progress has been made in the devel-
opment of cementless total hip arthroplasty (THA) in
recent years, a number of limitations remain. The implan-
tation of the femoral component requires a large surface
area of bone to be prepared [1]. Osteopenia due to non-
physiological loading and stress protection, distal migra-
tion of wear particles from the joint space or inadequate
stem fixation can increase the risk of aseptic loosening
and subsidence of the stem [2-4]. The use of a stiff femoral
component may lead to calcar atrophy and cortical thin-
ning, however modern titanium alloy femoral compo-
nents appear to reduce the risk of this stress-shielding
effect [5,6]. Moreover, intense research efforts have been
directed at characterising postoperative thigh pain, a clin-
ical limitation in THA that can range from immediate
mild postoperative symptoms to severe disabling pain
requiring revision surgery [7,8]. Micromotion, loosening,
uneven stress patterns or stem tip sclerosis seem to induce
such thigh pain [9,10]. Additionally, the use of a long
femoral stem increases the risk of thigh pain due to
impingement of the stem tip on the femoral cortex [11]
and a direct correlation has been drawn between thigh
pain and increased stem sizes [12]. Research has also been
conducted into ways to improve the limitations of tradi-
tional surgical techniques in THA. A less invasive surgical
technique may lead to less pain in the early postoperative
period and improve the postoperative functional status
[13,14] although the scientific discussion about the supe-
rior outcomes of this technique compared with the tradi-
tional surgical procedure is still ongoing [15,16].
To address such limitations, new THA implant designs
with shorter stems have been developed. Some designs,
such as the IPS™ [17], the Mayo Conservative Hip or the
Santori Custom stem [18,19] have involved shortening or
discarding much of the distal stem with the aim of max-
imising bone and soft tissue conservation. In addition,
anatomic short femoral prostheses can reduce the poten-
tial for stress-shielding in the femur through a more phys-
iological stress distribution to the proximal femur [20,21].
An uncemented, anatomic, proximally fixed femoral short
stem (the DePuy Proxima™ hip, DePuy International,
Leeds, UK) has been designed by a team of international
surgeons. The purpose of this study is to conduct a pro-
spective clinical trial to collect long-term clinical, patient
outcome and radiographic follow up data. Through the
long term follow-up, outcomes measures will be com-
pared to conventional cementless femoral components.
The present paper reports on the design rationale of this
new short stem prosthesis and the methodological design
of the study.
Proximal load transfer
In 1917, John C. Koch [22] proposed his model of the
mechanics of the loading of the hip, which included a
geometrical description of the femur and a calculation of
stresses induced by load that were assumed to occur dur-
ing gait. By correlating the stress patterns in the trabecular
bone with Wolff's [23] concepts of bone formation, Koch
assigned compressive and tensile forces along the medial
and lateral femoral surfaces. According to his theory, dur-
ing femoral loading, the superior neck and proximal lat-
eral three quarters of the femoral shaft were under tensile
loading while the distal lateral and entire medial femoral
surfaces were under compression. Koch's model was con-
sidered as the definitive model of hip biomechanics for
the next seventy years and served as a basis for the devel-
opment, design and validation of THA systems. However,
as Koch's static model did not sufficiently focus on the
function of soft tissues around the hip joint, Fetto et al.
[24] published an advanced model in 1995. Through the
inclusion of the iliotibial band as a static lateral tension
band and the gluteus medius-vastus lateralis complex as
dynamic tension bands along the lateral aspect of the
lower limb, the authors demonstrated that compressive
loading is actually generated both laterally and medially
throughout the femur distal to the greater trochanteric
apophysis during the unilateral support phase of gait. Fur-
ther consistency of this model was achieved by bone mor-
phology studies with cadaveric femora and femoral CT
scans, revealing a significant amount of cortical bone
mass at the lateral aspect of the femur. The authors there-
fore concluded that the femoral component of THA pros-
theses should engage the proximal lateral femoral cortex
as an additional area of support against subsidence, to
avoid stress-shielding and subsequent loss of proximal
femoral bone.
Lateral flare
Walker at al. [25] discovered fundamental changes in the
load transfer between stem and bone when comparing
contact pressures between femoral bone and standard
length straight stems or stems with a lateral flare. This
analysis showed, that for a standard straight stem, loads
are mainly transferred through the distal half of the stem
(Fig. 1a). In contrast, interface contact stresses from a
proximally fixed stem with a lateral flare demonstrated
that all of the loading from the prosthesis is transferred to
the proximal femur (Fig. 1b). Moreover, the magnitudes
of the interface stresses and distal migration during appli-
cation of the load were both lower in the lateral flare stem.
Additionally, results of radiographic follow-up from these
authors showed trabecular attachment onto the lateral
flare, providing indirect evidence of load transfer in that
area. Accordingly, Leali et al. [26] reviewed radiographs
from primary THAs with a lateral flare for axial migration
and stability. The proximally fixed cementless femoralBMC Musculoskeletal Disorders 2008, 9:147 http://www.biomedcentral.com/1471-2474/9/147
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component showed an average subsidence of 0.32 mm
after 2 years, which remained below 1 mm for the dura-
tion of the 24–104 month follow-up. The authors con-
cluded that a proximal lateral flare provides significant
initial stability, which has been shown to be vital to
obtain long-term stability through early bone ingrowth
[27]. Additionally, a dual-energy X-ray densitometry study
of stems with a lateral flare was performed, which demon-
strated that the bone content was preserved at the baseline
level or above throughout the follow-up period of 1 year.
This was particularly evident in the proximal prosthesis
support zones (Gruen zones 1, 2, 6 and 7) [28]. Likewise
bone mineral density around the Santori custom short
stem was significantly higher in zones 1 and 7 when com-
pared to other conventional cementless implants on a
three year follow up [29].
Product design
The DePuy Proxima™ hip (DePuy International, Leeds,
UK) is manufactured from titanium alloy (Ti-6AL-4V) and
has a lateral flare intended to conform to the lateral fem-
oral endosteal surface (Fig. 2). The stem has a 12/14 taper
and is available in high and standard offsets. The physio-
logical neck angle is set at 130° and the prosthesis is ana-
tomically shaped with an anteverted neck and available in
left and right versions. The entire proximal region of the
stem has a sintered bead porous coating with a thin layer
Interface contact stresses (MPA) normal to the surface of a  straight stem (1a) and a lateral flare stem (1b), in unbonded  conditions, without a collar and with zero interface friction Figure 1
Interface contact stresses (MPA) normal to the sur-
face of a straight stem (1a) and a lateral flare stem 
(1b), in unbonded conditions, without a collar and 
with zero interface friction.
A 
B 
The DePuy Proxima™ hip Figure 2
The DePuy Proxima™ hip.BMC Musculoskeletal Disorders 2008, 9:147 http://www.biomedcentral.com/1471-2474/9/147
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of Hydroxyapatite for optimized rapid osseointegration
and is stepped to minimise shear forces.
Surgical technique
Femoral components with a significant lateral flare
should be implanted with modified surgical insertion
technique, to minimise the potential risk of damage to the
greater trochanter [18]. Instruments and implants are
therefore first inserted in a slight varus position and then
rotated into the correct axial alignment. Adequate cancel-
lous bone for osseointegration should be left on the lat-
eral part of the femur whilst moving distally in the
femoral metaphysis. Initially a high neck cut is used, as
preservation of the femoral neck has been shown to pro-
vide an effective means to achieve immediate, post-oper-
ative torsional and coronal stability, which is a key factor
in the prevention of loosening of the femoral component
of THA [30,31]. Biomechanical stability of the new
implant was intensively tested and compared to other
clinically successful shaft prostheses prior to the start of
the clinical study [32,33].
Methods
Study design
This is a multi-centre, prospective, post marketing surveil-
lance study with a follow up period of 15 years (Clinical-
Trials.gov Identifier: NCT00208455). It will be open, non-
randomised and non-stratified. The primary objective is
to evaluate the five-year survivorship of the new cement-
less short stem. The secondary objectives of this investiga-
tion are to evaluate the long-term survivorship and the
clinical performance of the implant, the impact on the
subjects health related Quality of Life and the affect of the
prosthesis on bone mineral density.
Study population
The study will be conducted in four centres (UK, Italy,
Spain and Germany). The recruitment target is 200 sub-
jects, with each centre recruiting 50 subjects. The study has
been approved by the ethics committees of Southmead
LREC (Bristol, UK), Ospedale San Pietro (Rome, Italy),
Hospital Arnau de Vilanova (Valencia, Spain) and Univer-
sity of Regensburg (Regensburg, Germany). Patients
included will be aged between 18 and 70 years, suitable
for a cementless primary THA and able to understand the
study and co-operate with the study follow up visits. The
main primary diagnosis will be osteoarthritis. However,
other diagnoses will be included such as rheumatoid
arthritis, avascular necrosis, developmental dysplasia of
the hip or fractures. Excluded patients will be those with
other conditions or disorders, unrelated to their hip
replacement, that would affect their long-term involve-
ment in the study and patients already participating in
other research studies. Only one hip per patient is entered
into the study. Patients undergoing a simultaneous bilat-
eral or with a problematic or recent contralateral hip
replacement will also be excluded.
Intervention




The Harris Hip Score will be used to assess the clinical out-
comes. The Oxford Hip Score will be used to assess the
patient related outcomes. The effect of the implant on
bone mineral density will be assessed using DEXA analy-
sis.
Perioperative measurements
Demographic information such as height, weight and age
will be collected pre-operatively. In addition information
concerning the condition of the operative joint, primary
diagnosis, medical history and concomitant medical
problems will be collected. The Charnley and DORR clas-
sifications will be used to assess the pre-operative joint.
Baseline Harris Hip and Oxford Hip scores will also be
completed. Intra-operatively, surgical approach, average
surgical time, incision length, blood loss and details of
any operative complications will be recorded.
Radiographic evaluation
Radiographic evaluations will be done post-operatively
and at 3, 6, 12, 24, 60, 120 and 180 months follow up. At
each time-point standard AP and Lateral x-rays will be
taken and assessed. For the femoral implant signs of radi-
olucency and osteolysis will be recorded if observed and
subsidence will be assessed by recording the position of
the component at successive time-points. In addition, evi-
dence of positive bone response will be recorded. Given
the lack of a distal portion the Gruen zones have been
adapted (Fig. 3). For the acetabular component, evidence
of osteolysis or resorption will be recorded, any change in
position or orientation will be covered and wear will be
measured if possible.
Statistical analysis
The survivorship will be calculated using both revision
and radiological loosening of the implant as end-points
for the analysis. Kaplan-Meier survivorship curves will be
calculated. Analysis will be performed to assess whether
the patient or surgical characteristics have any affect on
the primary endpoints. In addition, multivariate analysis
using Cox's Proportional Hazards modeling will be
undertaken in relation to the survival analysis.
The statistical analysis will be performed by a qualified
Biostatistician (Gary Warriner, DePuy International,
Leeds, UK) using the statistical package SAS Version 8BMC Musculoskeletal Disorders 2008, 9:147 http://www.biomedcentral.com/1471-2474/9/147
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(SAS Institute Inc., SAS Campus Drive, Cary, North Caro-
lina 27513) and Microsoft Access. All significance tests
will be two-sided and carried out at a 5% significance
level, 95% confidence intervals will be regarded as appro-
priate.
All eligible subjects admitted to the study that receive
treatment, and have at least one usable post-treatment
assessment, will be included in the statistical analysis
where possible. Protocol violators will not be included in
the statistical analysis. If applicable, the number of ineli-
gible subjects that received treatment and the reasons for
ineligibility will be summarised.
Missing values will be excluded from the analysis as they
will be assumed to be missing completely at random and
so no loss of information or bias will occur if they are not
included in the analysis. If more than 20% of values are
missing for a particular analysis variable, then this may
significantly bias the results, hence further statistical
investigation methods may be employed to try and inves-
tigate the effect of missing values.
Subjects who withdraw or are lost to follow-up will be
included in the analysis up to the point of withdrawal or
last known assessment.
Discussion
Re-evaluation of the femoral biomechanics by Fetto et al.
has shown that the lateral femoral column can be effec-
tively used to carry compressive loads [26,34,35]. Starting
from that concept, Santori et al. developed and used a cus-
tom-made short stem with a well-defined lateral flare in
111 patients since 1995. Recent clinical and radiographic
reviews confirmed the excellent results and positive bone
remodelling of these implants [18,19,29]. An unce-
mented, anatomic, proximally fixed femoral short stem
that follows the concept of proximal load transfer through
a prominent lateral flare has therefore been developed by
an international team of surgeons. Due to the specific
shape of the stem an adapted insertion technique is
required to avoid damage to the great trochanter and glu-
teus muscles. The broaching and final implant insertion is
performed using a slight curved movement. Biomechani-
cal in vitro tests performed by Westphal et al. with this
implant show that adequate stability can be achieved with
the selection of a small implant size and cancellous fixa-
tion of the stem when good bone quality is present
[32,33]. Therefore, a sufficient amount of healthy cancel-
lous bone around the implant should already be consid-
ered in the pre-operative templating. To reduce the risk of
a varus movement through a higher lever arm, long and
extra long femoral heads should not be used with high
offset implants. The implant lends itself to minimal inva-
sive surgery done with a Smith-Petersen or MicroHip®
approach, where conventional straight stems with a lateral
shoulder may increase the risk of damaging the great tro-
chanter and/or the abductor tendons [36,37]. However,
one major concern in short hip stems is primary and tor-
sional stability. Whiteside et al. have shown that preserv-
ing the femoral neck can effectively reduce micromotion
and increase torsional stability [31].
Moreover, Leali et al. reported substantially less migration
during loading for lateral flare stems when compared to
conventional straight stems [26]. These biomechanical
observations confirm, that short stems in general are not
ideally suited to all patients. It is important to respect the
loading and fixation mechanics when using a metaphy-
seal implant. This relates to the loading applied to the
implant, the surface area available for fixation and the
quality of the bone stock. The purpose of the prospective
clinical study presented in this article is to collect clinical,
patient outcome and radiographic follow up data with a
new short stem for primary THA. Long-term follow up is
needed to verify stable fixation and continuing successful
clinical results with this uncemented, proximally fixed
anatomic femoral implant. The results of this study will be
presented as soon as they become available.
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